Biosimilar Hormones Market Report 2026
Download Free Sample Buy Now
Biosimilar Hormones Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Biosimilar Hormones Market Report 2026

Global Outlook – By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Therapeutics, Other Applications ), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biosimilar Hormones Market Overview

• Biosimilar Hormones market size has reached to $6.22 billion in 2025

• Expected to grow to $18.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.9%

• Growth Driver: Rising Healthcare Spending Accelerates Demand For The Market Due To Higher Patient Admissions And Expanding Access To Medical Care

• Market Trend: Novo Nordisk's Sogroya Injection Receives FDA Approval For Pediatric Use

• North America was the largest region in 2025.

What Is Covered Under Biosimilar Hormones Market?

Biosimilar hormones refer to the hormones included in the product that are chemically identical to those produced by your body. The hormones in bioidentical drugs may be identical to those used in conventional hormone therapy. They are used to treat people whose hormone levels are low or out of whack.

The main types of biosimilar hormones are teriparatidebiosimilars, follitropin alfa biosimilars, insulin biosimilars, somatropin biosimilars and others. Teriparatide is a parathyroid hormone recombinant (PTH). Teriparatide is similar to a component of human PTH, and when taken regularly, it stimulates osteoblasts more than osteoclasts, increasing bone mass. The different applications include research and biotechnology, diagnostics, biocatalysts, therapeutics, and others, and are distributed through various channels such as hospital and retail pharmacies, online pharmacies or e-pharmacy, and specialty clinics.

Biosimilar Hormones Market Global Report 2026 Market Report bar graph

What Is The Biosimilar Hormones Market Size and Share 2026?

The biosimilar hormones market size has grown exponentially in recent years. It will grow from $6.22 billion in 2025 to $7.68 billion in 2026 at a compound annual growth rate (CAGR) of 23.5%. The growth in the historic period can be attributed to rising prevalence of diabetes and hormonal disorders, high cost of branded hormone therapies, increasing aging population, growing awareness of hormone replacement therapies, expansion of hospital and retail pharmacy networks.

What Is The Biosimilar Hormones Market Growth Forecast?

The biosimilar hormones market size is expected to see exponential growth in the next few years. It will grow to $18.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to patent expiry of major biologic hormones, increasing regulatory support for biosimilars, growing demand for affordable endocrine treatments, expansion of online pharmacy distribution channels, rising investment in biosimilar R&D. Major trends in the forecast period include rising adoption of biosimilar hormones as cost-effective alternatives, increasing demand for insulin and growth hormone biosimilars, growing acceptance of biosimilar hormone therapies among physicians, expansion of biosimilar use in chronic and lifestyle diseases, improved regulatory pathways supporting biosimilar approvals.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Biosimilar Hormones Market Segmentation

1) By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types

2) By Application: Research & Biotechnology, Therapeutics, Other Applications

3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics

Subsegments:

1) By Teriparatide Biosimilars: Osteoporosis Treatment, Bone Health Maintenance

2) By Follitropin Alfa Biosimilars: Infertility Treatment, Assisted Reproductive Technology (ART)

3) By Insulin Biosimilars: Type 1 Diabetes Management, Type 2 Diabetes Management

4) By Somatropin Biosimilars: Growth Hormone Deficiency Treatment, Pediatric Growth Disorders

5) By Other Types: Thyroid Hormones, Corticosteroids

What Are The Drivers Of The Biosimilar Hormones Market?

The rising healthcare expenditure is expected to propel the growth of the biosimilar hormones market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure boosts the uptake of biosimilar hormones by increasing demand for cost-effective therapies and expanding patient access across healthcare systems. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the biosimilar hormones industry.

The increased prevalence of diabetes is expected to propel the growth of the biosimilar hormones market. Diabetes is a persistent health condition that impacts the body's ability to convert food into energy. Biosimilar hormones, including insulin, offer safe and efficient alternatives for managing diabetes, potentially resulting in reduced expenses and improved accessibility for patients. Biosimilar growth hormone can help in the treatment of diabetes by improving blood sugar control in adults with type 1 and type 2 diabetes. For instance, in June 2023, the International Diabetes Federation (IDF), a Germany-based umbrella organization of over 240 national diabetes associations, significant rise in diabetes cases, projecting 783 million adults aged 20-79 will have diabetes by 2045. Therefore, the increased prevalence of diabetes will be driving the growth of the biosimilar hormones industry going forward in the future.

Key Players In The Global Biosimilar Hormones Market

Major companies operating in the biosimilar hormones market are Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Mylan, Sanofi, Sandoz Group AG, LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy's Laboratories, Amgen Inc., Eli Lilly and Company, Celltrion Inc., Samsungbioepis Co.Ltd, Merck & Co., Biogen Inc., Boehringer Ingelheim, Alvotech, Cipla Limited, Lupin Ltd., Stada Arzneimittel AG, Torrent Pharmaceuticals, Zydus Cadila, Accord Healthcare, Hetero Drugs, Wockhardt

Global Biosimilar Hormones Market Trends and Insights

Major companies operating in the biosimilar hormones market are innovating new products, such as Sogroya (somapacitan-beco) injection, to increase their profitability in the market. Sogroya (somapacitan-beco) is a prescribed analog of human growth hormone (GH) utilized to treat individuals diagnosed with growth hormone deficiency (GHD). For instance, in April 2023, Novo Nordisk, a Denmark-based pharmaceutical company, got the FDA approval for a new indication for Sogroya (somapacitan-beco) injection for the treatment of children aged 2.5 years and older who have growth failure because of insufficient endogenous growth hormone secretion. Sogroya stands as the sole once-weekly growth hormone (GH) therapy designed for both children and adults. The approval was grounded on findings from the phase 3 REAL4 trial, demonstrating the effectiveness of Sogroya in addressing growth hormone deficiency (GHD) in pediatric patients.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the biosimilar hormones market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biosimilar Hormones Market?

The biosimilar hormones market consists of sales of estrace, estradil, and estring. Values in this market are """"factory gate values,"""" that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biosimilar Hormones Market Report 2026?

The biosimilar hormones market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar hormones industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Biosimilar Hormones Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $7.68 billion
Revenue Forecast In 2035 $18.12 billion
Growth Rate CAGR of 23.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Application, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Mylan, Sanofi, Sandoz Group AG, LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy's Laboratories, Amgen Inc., Eli Lilly and C
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Biosimilar Hormones Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Biosimilar Hormones Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Biosimilar Hormones Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Biosimilar Hormones Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Biosimilar Hormones As Cost-Effective Alternatives

4.2.2 Increasing Demand For Insulin And Growth Hormone Biosimilars

4.2.3 Growing Acceptance Of Biosimilar Hormone Therapies Among Physicians

4.2.4 Expansion Of Biosimilar Use In Chronic And Lifestyle Diseases

4.2.5 Improved Regulatory Pathways Supporting Biosimilar Approvals

5. Biosimilar Hormones Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Retail Pharmacies

5.4 Online Pharmacies

5.5 Research And Biotechnology Organizations

6. Biosimilar Hormones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biosimilar Hormones Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biosimilar Hormones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Biosimilar Hormones Market Size, Comparisons And Growth Rate Analysis

7.3. Global Biosimilar Hormones Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Biosimilar Hormones Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biosimilar Hormones Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biosimilar Hormones Market Segmentation

9.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types

9.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Research & Biotechnology, Therapeutics, Other Applications

9.3. Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics

9.4. Global Biosimilar Hormones Market, Sub-Segmentation Of Teriparatide Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Osteoporosis Treatment, Bone Health Maintenance

9.5. Global Biosimilar Hormones Market, Sub-Segmentation Of Follitropin Alfa Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infertility Treatment, Assisted Reproductive Technology (ART)

9.6. Global Biosimilar Hormones Market, Sub-Segmentation Of Insulin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type 1 Diabetes Management, Type 2 Diabetes Management

9.7. Global Biosimilar Hormones Market, Sub-Segmentation Of Somatropin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Growth Hormone Deficiency Treatment, Pediatric Growth Disorders

9.8. Global Biosimilar Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thyroid Hormones, Corticosteroids

10. Biosimilar Hormones Market Regional And Country Analysis

10.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biosimilar Hormones Market

11.1. Asia-Pacific Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biosimilar Hormones Market

12.1. China Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biosimilar Hormones Market

13.1. India Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biosimilar Hormones Market

14.1. Japan Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biosimilar Hormones Market

15.1. Australia Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biosimilar Hormones Market

16.1. Indonesia Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biosimilar Hormones Market

17.1. South Korea Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biosimilar Hormones Market

18.1. Taiwan Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biosimilar Hormones Market

19.1. South East Asia Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biosimilar Hormones Market

20.1. Western Europe Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biosimilar Hormones Market

21.1. UK Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biosimilar Hormones Market

22.1. Germany Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biosimilar Hormones Market

23.1. France Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biosimilar Hormones Market

24.1. Italy Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biosimilar Hormones Market

25.1. Spain Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biosimilar Hormones Market

26.1. Eastern Europe Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biosimilar Hormones Market

27.1. Russia Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biosimilar Hormones Market

28.1. North America Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biosimilar Hormones Market

29.1. USA Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biosimilar Hormones Market

30.1. Canada Biosimilar Hormones Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biosimilar Hormones Market

31.1. South America Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biosimilar Hormones Market

32.1. Brazil Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biosimilar Hormones Market

33.1. Middle East Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biosimilar Hormones Market

34.1. Africa Biosimilar Hormones Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Biosimilar Hormones Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biosimilar Hormones Market Regulatory and Investment Landscape

36. Biosimilar Hormones Market Competitive Landscape And Company Profiles

36.1. Biosimilar Hormones Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Biosimilar Hormones Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Biosimilar Hormones Market Company Profiles

36.3.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Gedeon Richter Plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Mylan Overview, Products and Services, Strategy and Financial Analysis

37. Biosimilar Hormones Market Other Major And Innovative Companies

Sanofi, Sandoz Group AG, LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy's Laboratories, Amgen Inc., Eli Lilly and Company, Celltrion Inc., Samsungbioepis Co.Ltd, Merck & Co., Biogen Inc., Boehringer Ingelheim, Alvotech

38. Global Biosimilar Hormones Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biosimilar Hormones Market

40. Biosimilar Hormones Market High Potential Countries, Segments and Strategies

40.1 Biosimilar Hormones Market In 2030 - Countries Offering Most New Opportunities

40.2 Biosimilar Hormones Market In 2030 - Segments Offering Most New Opportunities

40.3 Biosimilar Hormones Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Biosimilar Hormones Market, Overview Of Key Products - Product Examples
  • Table 2: Global Biosimilar Hormones Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Biosimilar Hormones Market, Supply Chain Analysis
  • Table 4: Global Biosimilar Hormones Market, Major Raw Material Providers
  • Table 5: Global Biosimilar Hormones Market, Major Resource Providers
  • Table 6: Global Biosimilar Hormones Market, Major Manufacturers (Suppliers)
  • Table 7: Global Biosimilar Hormones Market, Major Distributors And Channel Partners
  • Table 8: Global Biosimilar Hormones Market, Key Technologies & Future Trends
  • Table 9: Global Biosimilar Hormones Market, Major Trends
  • Table 10: Global Biosimilar Hormones Market, Major End Users
  • Table 11: Global Biosimilar Hormones Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Biosimilar Hormones Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Biosimilar Hormones Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Biosimilar Hormones Market - TAM, US$ Billion, 2025
  • Table 15: Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Biosimilar Hormones Market, Sub-Segmentation Of Teriparatide Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Biosimilar Hormones Market, Sub-Segmentation Of Follitropin Alfa Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Biosimilar Hormones Market, Sub-Segmentation Of Insulin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Biosimilar Hormones Market, Sub-Segmentation Of Somatropin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Biosimilar Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Biosimilar Hormones Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Biosimilar Hormones Market - Company Scoring Matrix
  • Table 99: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 100: Gedeon Richter Plc. Financial Performance
  • Table 101: Intas Pharmaceuticals Ltd. Financial Performance
  • Table 102: Biocon Limited Financial Performance
  • Table 103: Mylan Financial Performance
  • Table 104: Global Biosimilar Hormones Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Biosimilar Hormones Market, Competitive Dashboard
  • Table 106: Global Biosimilar Hormones Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 109: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Biosimilar Hormones Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Biosimilar Hormones Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Biosimilar Hormones Market, Supply Chain Analysis
  • Figure 4: Global Biosimilar Hormones Market, Major Raw Material Providers
  • Figure 5: Global Biosimilar Hormones Market, Major Resource Providers
  • Figure 6: Global Biosimilar Hormones Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Biosimilar Hormones Market, Major Distributors And Channel Partners
  • Figure 8: Global Biosimilar Hormones Market, Key Technologies & Future Trends
  • Figure 9: Global Biosimilar Hormones Market, Major Trends
  • Figure 10: Global Biosimilar Hormones Market, Major End Users
  • Figure 11: Global Biosimilar Hormones Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Biosimilar Hormones Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Biosimilar Hormones Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Biosimilar Hormones Market - TAM, US$ Billion, 2025
  • Figure 15: Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Biosimilar Hormones Market, Sub-Segmentation Of Teriparatide Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Biosimilar Hormones Market, Sub-Segmentation Of Follitropin Alfa Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Biosimilar Hormones Market, Sub-Segmentation Of Insulin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Biosimilar Hormones Market, Sub-Segmentation Of Somatropin Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Biosimilar Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Biosimilar Hormones Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Biosimilar Hormones Market - Company Scoring Matrix
  • Figure 99: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 100: Gedeon Richter Plc. Financial Performance
  • Figure 101: Intas Pharmaceuticals Ltd. Financial Performance
  • Figure 102: Biocon Limited Financial Performance
  • Figure 103: Mylan Financial Performance
  • Figure 104: Global Biosimilar Hormones Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Biosimilar Hormones Market, Competitive Dashboard
  • Figure 106: Global Biosimilar Hormones Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 109: Global, Biosimilar Hormones Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Next-Gen Colorectal Cancer Drugs : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Colorectal Cancer Drugs : Market Forecast, Transformation, and Long-Term Trajectories

Contract Research And Manufacturing Services (CRAMS) Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Contract Research And Manufacturing Services (CRAMS) Growth Trajectory: Key Forecasts and Strategic Insights

Cough And Cold Preparations Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Cough And Cold Preparations Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Cough And Cold Preparations Market Landscape: Innovative Technologies Transforming Drug Discovery Landscape

Read More About Emerging Trends Redefining the Cough And Cold Preparations Market Landscape: Innovative Technologies Transforming Drug Discovery Landscape

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Hormonal Contraceptives Market 2022 – By Product ( Pills, Injectable Birth Control, Vaginal Rings), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers), By Hormones (Proge...

Branded Generics Market Report 2026 - Global Outlook – By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Other Drugs...

Anti-Thyroid Drugs Market Report 2026 - Global Outlook – By Drug Type (Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)), By Route of Administration (Oral, Intravenous, Other Route O...

Breast Cancer Monoclonal Antibodies Market Report 2026 - Global Outlook – By Product (Naked Mabs, Conjugated Mabs ), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Th...

G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2026 - Global Outlook – By Type (Pegfilgrastim, Lenograstim, Filgrastim, Other Types), By Product Form (Tablet, Capsule, Other Product Forms), By Application (...

Hormonal Contraceptives Market Report 2026 - Global Outlook – By Product (Pills, Injectable Birth Control, Vaginal Rings, Others), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgic...

Biosimilar Growth Hormones Market Report 2026 - Global Outlook – By Route Of Administration (Subcutaneous, Intramuscular, Oral ), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prad...

Parathyroid Hormone Market Report 2026 - Global Outlook – By Disease Type (Hypocalcemia, Hypoparathyroidism ), By Product Type (Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues), By End-User (Hospitals, Cli...

Frequently Asked Questions

The Biosimilar Hormones Market Report 2026 market was valued at $6.22 billion in 2025, increased to $7.68 billion in 2026, and is projected to reach $18.12 billion by 2030. request a sample here

The expected CAGR for the Biosimilar Hormones Market Report 2026 market during the forecast period 2025–2030 is 23.9%. request a sample here

Major growth driver of the market includes: Rising Healthcare Spending Accelerates Demand For The Market Due To Higher Patient Admissions And Expanding Access To Medical Care in the Biosimilar Hormones Market Report 2026 market. For further insights on this market, request a sample here

The biosimilar hormones market covered in this report is segmented –
1) By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types
2) By Application: Research & Biotechnology, Therapeutics, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics Subsegments:
1) By Teriparatide Biosimilars: Osteoporosis Treatment, Bone Health Maintenance
2) By Follitropin Alfa Biosimilars: Infertility Treatment, Assisted Reproductive Technology (ART)
3) By Insulin Biosimilars: Type 1 Diabetes Management, Type 2 Diabetes Management
4) By Somatropin Biosimilars: Growth Hormone Deficiency Treatment, Pediatric Growth Disorders
5) By Other Types: Thyroid Hormones, Corticosteroids request a sample here

Major trend in this market includes: Novo Nordisk's Sogroya Injection Receives FDA Approval For Pediatric Use For further insights on this market, request a sample here.

Major companies operating in the Biosimilar Hormones Market Report 2026 market are Major companies operating in the biosimilar hormones market are Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Myl request a sample here.

North America was the largest region in the biosimilar hormones market in 2025. The regions covered in the biosimilar hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us